Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus, but the drugs have different approvals and different usages according to the manufacturer and the FDA
More research needs to be done and guidelines have yet to be established, but as clinicians seeking to understand obesity medicine, this is a step in the right direction for some of our most challenging patients
Vidal-Alaball J, Butler CC, Cannings-John R, et al
Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis
Tirzepatide is a new class of medication that was first approved for type 2 diabetes but has since gained recognition for its powerful weight loss effects
Urinary protein 2 plus, occult blood and glucose were negative at the start of semaglutide administration